These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 10461605

  • 1. Comparison of exercise, dipyridamole, adenosine, and dobutamine stress with the use of Tc-99m tetrofosmin tomographic imaging.
    Levine MG, Ahlberg AW, Mann A, White MP, McGill CC, Mendes de Leon C, Piriz JM, Waters D, Heller GV.
    J Nucl Cardiol; 1999; 6(4):389-96. PubMed ID: 10461605
    [Abstract] [Full Text] [Related]

  • 2. Comparison of technetium-99m tetrofosmin and thallium-201 single-photon emission computed tomographic imaging for detection of myocardial perfusion defects in patients with coronary artery disease.
    Shanoudy H, Raggi P, Beller GA, Soliman A, Ammermann EG, Kastner RJ, Watson DD.
    J Am Coll Cardiol; 1998 Feb; 31(2):331-7. PubMed ID: 9462576
    [Abstract] [Full Text] [Related]

  • 3. Impact of limited treadmill exercise on adenosine Tc-99m sestamibi single-photon emission computed tomographic myocardial perfusion imaging in coronary artery disease.
    Jamil G, Ahlberg AW, Elliott MD, Hendel RC, Holly T, McGill CC, Sarkis M, White MP, Mather JF, Waters DD, Heller GV.
    Am J Cardiol; 1999 Aug 15; 84(4):400-3. PubMed ID: 10468076
    [Abstract] [Full Text] [Related]

  • 4. Enhanced detection of reversible perfusion defects by Tc-99m sestamibi compared to Tc-99m tetrofosmin during vasodilator stress SPECT imaging in mild-to-moderate coronary artery disease.
    Soman P, Taillefer R, DePuey EG, Udelson JE, Lahiri A.
    J Am Coll Cardiol; 2001 Feb 15; 37(2):458-62. PubMed ID: 11216963
    [Abstract] [Full Text] [Related]

  • 5. Outcome prediction in patients at high risk for coronary artery disease: comparison between 99mTc tetrofosmin and 99mTc sestamibi.
    Borges-Neto S, Tuttle RH, Shaw LK, Smith WT, Jain D, Coleman RE, Whellan D.
    Radiology; 2004 Jul 15; 232(1):58-65. PubMed ID: 15220493
    [Abstract] [Full Text] [Related]

  • 6. [Myocardial perfusion scintigraphy with Tc-99m MIBI in patients with left bundle branch block: Visual quantification of the anteroseptal perfusion imaging for the diagnosis of left anterior descending artery stenosis].
    Möller J, Warwick J, Bouma H.
    Cardiovasc J S Afr; 2005 Jul 15; 16(2):95-101. PubMed ID: 15915276
    [Abstract] [Full Text] [Related]

  • 7. Tc-99m tetrofosmin myocardial perfusion SPECT after dipyridamole combined with low-level exercise in the diagnosis of coronary artery disease.
    Fukuzawa S, Ozawa S, Inagaki M, Inoue T, Morooka S, Sugioka J.
    Ann Nucl Med; 1996 May 15; 10(2):231-5. PubMed ID: 8800453
    [Abstract] [Full Text] [Related]

  • 8. Assessment of adenosine, arbutamine and dobutamine as pharmacological stress agents during (99m)Tc-tetrofosmin SPECT imaging: a randomized study.
    Wright DJ, Williams SG, Lindsay HS, Sheard KL, Thorley PJ, Sivananthan UM.
    Nucl Med Commun; 2001 Dec 15; 22(12):1305-11. PubMed ID: 11711900
    [Abstract] [Full Text] [Related]

  • 9. Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi.
    Flamen P, Bossuyt A, Franken PR.
    J Nucl Med; 1995 Nov 15; 36(11):2009-15. PubMed ID: 7472590
    [Abstract] [Full Text] [Related]

  • 10. Dobutamine technetium-99m tetrofosmin SPECT imaging for the diagnosis of coronary artery disease in patients with limited exercise capacity.
    Elhendy A, Sozzi FB, Valkema R, van Domburg RT, Bax JJ, Roelandt JR.
    J Nucl Cardiol; 2000 Nov 15; 7(6):649-54. PubMed ID: 11144480
    [Abstract] [Full Text] [Related]

  • 11. Comparison of defect size between thallium-201 and technetium-99m tetrofosmin myocardial single-photon emission computed tomography in patients with single-vessel coronary artery disease.
    Matsunari I, Fujino S, Taki J, Senma J, Aoyama T, Wakasugi T, Hirai J, Saga T, Tonami N, Hisada K.
    Am J Cardiol; 1996 Feb 15; 77(5):350-4. PubMed ID: 8602561
    [Abstract] [Full Text] [Related]

  • 12. Technetium 99m-labeled tetrofosmin myocardial tomography in patients with coronary artery disease: comparison between adenosine and dynamic exercise stress testing.
    Cuocolo A, Nicolai E, Soricelli A, Pace L, Nappi A, Sullo P, Cardei S, Argenziano L, Ell PJ, Salvatore M.
    J Nucl Cardiol; 1996 Feb 15; 3(3):194-203. PubMed ID: 8805739
    [Abstract] [Full Text] [Related]

  • 13. Technetium-99m sestamibi and tetrofosmin myocardial single-photon emission tomography: can we use the same reference data base?
    Widding A, Hesse B, Gadsboll N.
    Eur J Nucl Med; 1997 Jan 15; 24(1):42-5. PubMed ID: 9044875
    [Abstract] [Full Text] [Related]

  • 14. Value of gating of technetium-99m sestamibi single-photon emission computed tomographic imaging.
    Smanio PE, Watson DD, Segalla DL, Vinson EL, Smith WH, Beller GA.
    J Am Coll Cardiol; 1997 Dec 15; 30(7):1687-92. PubMed ID: 9385894
    [Abstract] [Full Text] [Related]

  • 15. Incremental value of exercise technetium-99m tetrofosmin myocardial perfusion single-photon emission computed tomography for the prediction of cardiac events.
    Schinkel AF, Elhendy A, van Domburg RT, Bax JJ, Vourvouri EC, Bountioukos M, Rizzello V, Agricola E, Valkema R, Roelandt JR, Poldermans D.
    Am J Cardiol; 2003 Feb 15; 91(4):408-11. PubMed ID: 12586253
    [Abstract] [Full Text] [Related]

  • 16. Dipyridamole-dobutamine stress with Tc-99m sestamibi tomographic myocardial perfusion imaging.
    Shehata AR, Ahlberg AW, White MP, Mann A, Fleming IA, Levine MG, Mather JF, Waters D, Heller GV.
    Am J Cardiol; 1998 Aug 15; 82(4):520-3. PubMed ID: 9723645
    [Abstract] [Full Text] [Related]

  • 17. Eleven-year prognostic value of dobutamine stress (99m)Tc-sestamibi myocardial perfusion imaging in patients with limited exercise capacity.
    Boiten HJ, van Domburg RT, Valkema R, Schinkel AF.
    Am J Cardiol; 2015 Apr 01; 115(7):884-9. PubMed ID: 25661571
    [Abstract] [Full Text] [Related]

  • 18. Assessing coronary artery disease with dipyridamole technetium-99m-tetrofosmin SPECT: a multicenter trial.
    He ZX, Iskandrian AS, Gupta NC, Verani MS.
    J Nucl Med; 1997 Jan 01; 38(1):44-8. PubMed ID: 8998148
    [Abstract] [Full Text] [Related]

  • 19. Direct comparison of technetium 99m-sestamibi and technetium 99m-tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery disease.
    Acampa W, Cuocolo A, Sullo P, Varrone A, Nicolai E, Pace L, Petretta M, Salvatore M.
    J Nucl Cardiol; 1998 Jan 01; 5(3):265-74. PubMed ID: 9669581
    [Abstract] [Full Text] [Related]

  • 20. Prediction of 14-year cardiovascular outcomes by dobutamine stress 99mTc-tetrofosmin myocardial perfusion SPECT in elderly patients unable to perform exercise testing.
    Roest S, Boiten HJ, van Domburg RT, Valkema R, Schinkel AFL.
    J Nucl Cardiol; 2018 Feb 01; 25(1):63-71. PubMed ID: 27381341
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.